Reply to Wijmans et al.: Optical Coherence Tomography: A Valuable Novel Tool for Assessing the Alveolar Compartment in Interstitial Lung Disease?

Am J Respir Crit Care Med. 2018 May 1;197(9):1232-1233. doi: 10.1164/rccm.201711-2347LE.

Authors

Lida P Hariri^{1

2}, David C Adams^{1

2}, John C Wain^{1

2}, Michael Lanuti^{1

2}, Ashok Muniappan^{1

2}, Amita Sharma^{1

2}, Thomas V Colby³, Mari Mino-Kenudson^{1

2}, Eugene J Mark^{1

2}, Richard L Kradin^{1

2}, Hannah Goulart¹, Melissa J Suter^{1

2}

Affiliations

¹ 1 Massachusetts General Hospital Boston, Massachusetts.
² 2 Harvard Medical School Boston, Massachusetts and.
³ 3 Mayo Clinic Scottsdale, Arizona.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Comment

MeSH terms

Humans
Idiopathic Pulmonary Fibrosis*
Lung Diseases, Interstitial*
Risk Assessment
Tomography, Optical Coherence

Grants and funding